Jannatul Fardous

Dr. Jannatul Fardous


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZYZHOU YU
ZHOU YU
WLWU Lichun
WU Lichun
YZYi Zhang
Yi Zhang
JHJia Hu
Jia Hu
JFJannatul Fardous
Jannatul Fardous
HIHiroyuki Ijima
Hiroyuki Ijima
External environmental stressors and internal physiological changes frequently compromise the skin barrier, resulting in conditions such as dermatitis and dehydration. A key underlying factor is the depletion of ceramides, essential lipids in the stratum corneum that maintain skin integrity. Although topical ceramide supplementation is effective for barrier repair, its clinical application is limited by poor solubility and low skin permeability. To overcome these challenges, this study developed an oil-in-water nanoemulsion (O/W-NE) using ultrasonic emulsification for the efficient transdermal delivery of ceramide C2. Octyldodecanol was selected as the oil phase to enhance ceramide solubility, while glycerin was incorporated to increase aqueous phase viscosity, reduce particle size, and function as a biocompatible penetration enhancer. The optimized nanoemulsion achieved a particle size of 112.5 nm and an encapsulation efficiency of 85%. Its performance was evaluated via in vitro release, ex vivo skin permeation, and in vivo biocompatibility studies. Mechanistic investigations revealed that both particle size and glycerin concentration significantly influenced ceramide penetration into the epidermis and dermis. Additionally, the nanoemulsion exhibited moisturizing and barrier-repair effects in a damaged skin model. Overall, this O/W-NE offers a stable, non-invasive strategy for enhancing ceramide delivery and restoring skin barrier function.

26 November 2024 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
YZYi Zhang
Yi Zhang
JFJannatul Fardous
Jannatul Fardous
ZYZHOU YU
ZHOU YU
WLWU Lichun
WU Lichun
RDRyota Doi
Ryota Doi
HIHiroyuki Ijima
Hiroyuki Ijima

17 July 2026 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
TSTamanna Sultana
Tamanna Sultana
MUMonir Uzzaman
Monir Uzzaman
MPMd. Kawchar Ahmed Patwary
Md. Kawchar Ahmed Patwary
MKMd. Limon Khan
Md. Limon Khan
MJMd. Jihad
Md. Jihad
JFJannatul Fardous
Jannatul Fardous
Allium schoenoprasum L. (Amaryllidaceae) is a widely distributed herb traditionally used for cardiovascular, respiratory, and urinary health, with recent studies highlighting its antioxidant, anti-inflammatory, anticancer, and antihypertensive activities. The present study aimed to evaluate the antioxidant, anti-inflammatory, and antidiabetic activities of methanolic and aqueous extracts of A. schoenoprasum L. using in vitro assays, alongside comprehensive in silico analyses to explore the molecular interactions and pharmacological potential of its phytochemicals. Phytochemical quantification revealed that the methanolic extract possessed the highest total phenolic (101.26 ± 9.07 mg GAE/g) and flavonoid contents (49.21 ± 4.11 mg QE/g), which correlated with pronounced antioxidant activity (IC₅₀ = 111.46 ± 1.99 µg/mL). The same extract also demonstrated notable anti-inflammatory potential (IC₅₀ = 114.57 ± 1.29 µg/mL). GC-MS profiling identified a diverse range of compounds, from which nine representative phytochemicals were selected for geometry optimization using density functional theory (DFT) at the B3LYP/6–31 + G (d, p) level. In vitro antidiabetic evaluation showed significant inhibitory activity against α-amylase (IC₅₀ = 65.05 µg/mL) and α-glucosidase (IC₅₀ = 79.46 µg/mL). Molecular docking analysis indicated that 9,12-octadecadienoic acid, methyl ester (C-1; −6.5 kcal/mol) and hexadecanamide (C-6; −6.3 kcal/mol) exhibited the highest binding affinities toward human pancreatic α-amylase (PDB ID: 4GQQ), suggesting a possible association with the observed biological activity, although no direct attribution can be made without compound isolation and validation. Molecular dynamics simulations using YASARA confirmed protein-ligand stability and conformational adaptability. Additionally, ADMET and PASS analyses suggested favorable pharmacokinetic profiles and diverse biological activities. Collectively, these findings provide a robust foundation for future in vivo studies and highlight A. schoenoprasum L. as a promising candidate for therapeutic development.

3 July 2026 in Sciences of Phytochemistry
Verified
Journal Article
Open access
PDF file
FRFakhray Rimi
Fakhray Rimi
JFJannatul Fardous
Jannatul Fardous
FZFahmida Zaman
Fahmida Zaman
MPMd. Kawchar Ahmed Patwary
Md. Kawchar Ahmed Patwary
MMMahajabin Maisha
Mahajabin Maisha
Medicinal plants have been used in traditional medicine to alleviate a range of neurological and psychological disorders. Numerous plant-derived phytochemicals are known to modulate central nervous system activity by interacting with neurotransmitters, receptors, and neurochemical pathways. This review provides a comprehensive overview of medicinal plants with psychoactive properties, their major bioactive constituents, mechanisms of action, therapeutic potential, toxicity concerns, and regulatory considerations. Literature was collected from scientific databases, including PubMed, Scopus, ScienceDirect, Web of Science, and Google Scholar, using relevant keywords on psychoactive medicinal plants and neuropharmacological activities. Twenty medicinal plants commonly associated with anxiolytic, antidepressant, sedative, hallucinogenic, or cognition-enhancing effects were reviewed. Major phytochemical classes identified included alkaloids, flavonoids, terpenoids, phenolic compounds, cannabinoids, and saponins. Several plants, such as Withania somnifera, Cannabis sativa, Valeriana officinalis, Psilocybe cubensis, and Passiflora incarnata, have been reported to exhibit neuropharmacological activities in preclinical and limited clinical studies, through modulation of serotonergic, dopaminergic, GABAergic, and endocannabinoid systems. In addition to psychoactive effects, many reviewed plants exhibited antioxidant, anti-inflammatory, neuroprotective, and adaptogenic properties. However, despite promising pharmacological findings, most available evidence remains preclinical, with limited clinical validation regarding efficacy, safety, standardization, and long-term use. This review highlights the therapeutic prospects and current limitations of psychoactive medicinal plants and emphasizes the need for further experimental and clinical investigations for safe and evidence-based therapeutic applications.